Expression of CD147 Mediates Tumor Cells Invasion and Multidrug Resistance in Hepatocellular Carcinoma

REFERENCES

• Kerbel R., Korczak S., Lagarde B. A. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 1990; 5: 87–132
   Google Scholar
• Su Z. Z., Austin V. N., Zimmer S. G., Fisher P. B. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 1993; 8: 1211–1219
   PubMed Web of Science ®Google Scholar
• Yang J. M., Xu Z., Wu H., Zhu H., Wu X., Hait W. N. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003; 1: 420–427
   PubMed Web of Science ®Google Scholar
• Zou W., Zhu H., Wu X. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett 2006; 248: 211–218
   PubMed Web of Science ®Google Scholar
• Li Q. Q., Wang W. J., Xu J. D., Cao X. X., Chen Q., Yang J. M., Xu Z. D. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci 2007; 98: 1064–1069
   PubMed Web of Science ®Google Scholar
• Nelson A. R., Fingleton B., Rothenberg M. L., Matrisian L. M. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135–1149
   PubMed Web of Science ®Google Scholar
• Illemann M., Bird N., Majeed A., Sehested M., Laerum O. D., Lund L. R., Dano K., Nielsen B. S. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 2006; 4: 293–302
   PubMed Web of Science ®Google Scholar
• Rio M. C. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. Biochimie 2005; 87: 299–306
   PubMed Web of Science ®Google Scholar
• Chan H. S., Thorner P. S., Haddad G., Ling V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 8: 689–704
   PubMed Web of Science ®Google Scholar
• Verrelle P., Meissonnier F., Fonck Y., Feillel V., Dionet C., Kwiatkowski F., Plagne R., Chassagne J. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 1991; 83: 111–116
   PubMed Web of Science ®Google Scholar
• Yang J. M., Yang G. Y., Medina D. J., Vassil A. D., Liao J., Hait W. N. Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease. BBRC 1999; 266: 167–173
   PubMed Web of Science ®Google Scholar
• Weinstein R. S., Jakate S. M., Dominguez J. M., Lebovitz M. D., Koukoulis G. K., Kuszak J. R., Klusens L. F., Grogan T. M., Saclarides T. J., Roninson I. B., Coon J. S. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991; 51: 2720–2726
   PubMed Web of Science ®Google Scholar
• Ding S., Chamberlain M., McLaren A., Goh L., Duncan I., Wolf C. R. Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer 2001; 85: 1175–1184
   PubMed Web of Science ®Google Scholar
• Davidson B., Givant-Horwitz V., Laranovici P., Risberg B., Nesland J. M., Trope C. G., Schaefer E., Reich R. Matrix rnetalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma. Clin Exp Metastasis 2002; 20: 621–631
   Web of Science ®Google Scholar
• Lim M., Martinez T., Jablons D., Cameron R., Guo H., Toole B., Li J. D., Basbaum C. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 1998; 441: 88–92
   PubMed Web of Science ®Google Scholar
• Khunkeawla P., Moonsom S., Staffler G., Kongtawelert P., KasinrerK W. Engagement of CD147 molecule-induced cell aggregation through the activation of protein kinases and reorganization of the cytoskeleton. Immunobiol 2001; 203: 659–669
   PubMed Web of Science ®Google Scholar
• Jia L., Wang H., Qu S., Miao X., Zhang J. CD147 Regulates Vascular Endothelial Growth Factor-A Expression, Tumorigenicity, and Chemosensitivity to Curcumin in Hepatocellular Carcinoma. IUBMB Life 2008; 60: 57–63
   PubMed Web of Science ®Google Scholar
• Misra S., Ghatak S., Zoltan-Jones A., Toole B. P. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 2003; 278: 25285–25288
   PubMed Web of Science ®Google Scholar
• Muramatsu T., Miyauchi T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 2003; 18: 981–987
   PubMed Web of Science ®Google Scholar
• Yan L. S., Zucker B. P. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemos 2005; 93: 199–204
   PubMed Web of Science ®Google Scholar
• Kanekura T., Chen X., Kanzaki T. Basigin (CD147) is system with an improved hairpin and its significant expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 520–528
   PubMed Web of Science ®Google Scholar
• Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M., Podhajcer O. L., Chenard M. P., Rio M. C., Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348: 699–704
   PubMed Web of Science ®Google Scholar
• Delebecq T. J., Porte H., Zerimech F., Copin M. C., Dacquembronne V., Gouyer E. Overexpression level of stromelysin 3 is related to the lymph node involvement in nonsmall cell lung cancer. Clin Cancer Res 2000; 6: 1086–1092
   PubMed Web of Science ®Google Scholar
• Deng H., Guo R. F., Li W. M., Zhao M., Lu Y. Y. Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. BBRC 2005; 14: 274–281
   Google Scholar
• Noel A., Boulay A., Kebers F., Kannan R., Hajitou A., CalbergBacq C. M. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene 2000; 19: 1605–1612
   PubMed Web of Science ®Google Scholar
• Sameshima T., Nabeshima K., Toole B. P., Yokogami K., Okada Y., Goya T., Koono M., Wakisaka S. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membranetype matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000; 157: 177–184
   PubMed Web of Science ®Google Scholar
• Jiang J. L., Zhou Q., Yu M. K., Ho L. S., Chen Z. N., Chan H. C. The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem 2001; 276: 46870–46877
   PubMed Web of Science ®Google Scholar
• Jia L., Cao J., Wei W., Wang S., Zuo Y., Zhang J. CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine Hepatocarcinoma Hca-F. IJBCB 2007; 39: 2135–2142
   Web of Science ®Google Scholar
• Osborn M. T., Chambers T. C. Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotherapeutic drugs. J Biol Chem 1996; 271: 30950–30955
   PubMed Web of Science ®Google Scholar
• Yang J. M., Vassil A. D., Hait W. N. Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway. Mol Pharmacol 2001; 60: 674–680
   PubMed Web of Science ®Google Scholar
• Huang C., Jacobson K., Schaller M. D. MAP kinases and cell mobility. J Cell Sci 2004; 117: 4619–4628
   PubMed Web of Science ®Google Scholar
• Brauchle M., Gluck D., Padova F. D., Han J. H., Gram H. Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1. Exp Cell Res 2000; 258: 135–144
   PubMed Web of Science ®Google Scholar
• Xu H. Y., Qian A. R., Shang P., Xu J., Kong L. M., Bian H. J., Chen Z. N. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway. Cancer Lett 2007; 18: 336–344
   Google Scholar
• Gabison E. E., Hoang-Xuan T., Mauviel A. Menasshi, S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005; 87: 361–368
   Google Scholar